Standout Papers
- Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. (2002)
Citation Impact
Citing Papers
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
2008
MGMT -STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951
2013
Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study
2005
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
2012
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
2012
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
2012
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2006
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
2009
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
2018
Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
2010
Stroke rehabilitation
2011 Standout
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients
2014
Control of cancer-related anemia with erythropoietic agents:a review of evidence for improved quality of life and clinical outcomes
2003
IDH1andIDH2Mutations in Gliomas
2009 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
The Vascular Basement Membrane as “Soil” in Brain Metastasis
2009
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
2017
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
2015
Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer
2008
Advances in Radiation Therapy for Brain Tumors
2007
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
2003 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy
2004
Cancer Metastasis: Building a Framework
2006 Standout
High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
2010
Glioblastoma and Other Malignant Gliomas
2013 Standout
Head and neck cancer
2008 Standout
Current concepts and new horizons in conservation laryngeal surgery: An important part of multidisciplinary care
2009
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Thromboembolic disease in patients with high-grade glioma
2012
Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies
2008
Anemia
2003
Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx
2000
The epidermal growth factor receptor mediates radioresistance
2003
Quality assurance in the EORTC 22921 trial on preoperative radiotherapy with or without chemotherapy for resectable rectal cancer
2002
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas
2007
Psychosocial and supportive-care needs in high-grade glioma
2008
Mechanisms of Disease: genetic predictors of response to treatment in brain tumors
2007
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
2011
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
The golden age: gold nanoparticles for biomedicine
2011 Standout
Oesophageal carcinoma
2013 Standout
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
Quantitative imaging biomarkers in neuro-oncology
2009
Malignant Gliomas in Adults
2008 Standout
Therapies Directed Against Epidermal Growth Factor Receptor in Aerodigestive Carcinomas
2007
Inhibiting kinases in malignant gliomas
2007
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
2003
The impact of hemoglobin levels on treatment outcomes in patients with cancer
2001
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma
2010
State-of-the-art management of locally advanced head and neck cancer
2005
PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
2010
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway
2004
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
2004
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Primary brain tumours in adults
2012 Standout
Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
2001
Laryngeal preservation in head and neck cancer: multidisciplinary approach
2006
High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study
2008
Prevalence of anemia in cancer patients undergoing radiation therapy
2001
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly
2007
Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas
2012
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
2006 Standout
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
High-dose methotrexate for elderly patients with primary CNS lymphoma
2008
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010
Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?
2010
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Dysphagia treatment post stroke: a systematic review of randomised controlled trials
2008
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Anemia of Chronic Disease
2005 Standout
Epidermal growth factor receptor and its inhibition in radiotherapy:in vivofindings
2003
Brain Metastases from Thyroid Carcinoma: A Retrospective Study of 21 Patients
2013
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
2006
Primary CNS Lymphoma in Immunocompetent Patients
2009
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck
2005
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
2007
Head and Neck Cancer
2020 Standout
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
Oxaliplatin in Combination With Protracted-Infusion Fluorouracil and Radiation: Report of a Clinical Trial for Patients With Esophageal Cancer
2002
Prevention and Treatment of Dysphagia and Aspiration After Chemoradiation for Head and Neck Cancer
2006
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck
2004
Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610
2008
Constitutive and inducible expression and regulation of vascular endothelial growth factor
2004
Therapeutic Application of Noncytotoxic Molecular Targeted Therapy in Gliomas: Growth Factor Receptors and Angiogenesis Inhibitors
2008
Moving toward molecular classification of diffuse gliomas in adults
2012
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
2006 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
2008
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
2009
Breast Cancer Treatment
2019 Standout
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
2008
Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With Cetuximab
2007
In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy
2008
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
2003
Significance of Necrosis in Grading of Oligodendroglial Neoplasms: A Clinicopathologic and Genetic Study of Newly Diagnosed High-Grade Gliomas
2006
Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience
2009
Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer
2007
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
2007
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma
2007
Adjuvant Therapy in Patients With Resected Poor-Risk Head and Neck Cancer
2006
Optical Systems for in Vivo Molecular Imaging of Cancer
2003
Prognostic Value of an Activation State Marker for Epidermal Growth Factor Receptor in Tissue Microarrays of Head and Neck Cancer
2006
Lessons learned in the development of targeted therapy for malignant gliomas
2007
Phase I/II Study of Cetuximab in Combination With Cisplatin or Carboplatin and Fluorouracil in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
2006
Medical Management of Brain Metastases and Leptomeningeal Disease in Patients with Breast Carcinoma
2018
Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting
2006
Absorption by water increases fluorescence image contrast of biological tissue in the shortwave infrared
2018 StandoutNobel
Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy
2004
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
2005
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
2014
Works of Brian Berkey being referenced
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
2006
Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27
1998
Validation of the RTOG recursive partitioning classification for head and neck tumors
2001
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial
2007
Outcome of Salvage Total Laryngectomy Following Organ Preservation Therapy
2003
The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus
1999
Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 Patterns of Care process survey.
1998
Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90-03
2005
Anaplastic Oligodendroglial Tumors: Refining the Correlation among Histopathology, 1p 19q Deletion and Clinical Outcome in Intergroup Radiation Therapy Oncology Group Trial 9402
2008
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
2007
Initial report of Radiation Therapy Oncology Group (RTOG) 9802: Prospective studies in adult low-grade glioma (LGG)
2006
A randomized trial comparing conventional dose (70.2GyE) and high-dose (79.2GyE) conformal radiation in early stage adenocarcinoma of the prostate: Results of an interim analysis of PROG 95–09
2004
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial
2008
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
2002 Standout
An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastoma
2006
Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model
2006
A randomized trial comparing conventional dose (70.2GyE) and high-dose (79.2GyE) conformal radiation in early stage adenocarcinoma of the prostate: Results of an interim analysis of PROG 95–09
2004